Company Profile
Butterfly Network, Inc. is a US-based manufacturer of handheld ultrasound systems, headquartered in 1600 District Avenue, Burlington, Massachusetts 01803, United States. Founded in 2011 by Dr. Jonathan Rothberg, the company operates as an independent publicly traded entity on NYSE (BFLY), led by Chairman, President and CEO Joseph DeVivo, serving healthcare practitioners, hospitals and clinics in over 20 countries. The company employs approximately 220 staff and maintains additional offices in Guilford, Connecticut and New York City.
Core Products ＆ Technologies
Handheld Ultrasound Devices
• Butterfly iQ: The world's first handheld, single-probe, whole-body ultrasound system launched in 2018, integrating linear, convex and phased array imaging in one probe
• Butterfly iQ+: The second-generation device with improved image quality, durability and faster processing, launched in 2020
• Butterfly iQ3: The third-generation system built on the proprietary P4.3 semiconductor platform, featuring double the data transfer rate, iQ Slice and iQ Fan advanced 3D capabilities, launched in 2024
• Butterfly iQ+ Bladder: A specialty product for bladder volume scanning and assessment, launched in the United States in 2024
• Butterfly iQ+ Vet: A handheld ultrasound system designed for veterinary applications, launched in 2021
Software, AI ＆ Cloud Solutions
• Butterfly Academy: An education platform providing in-app tutorials, formal courses and certification programs for ultrasound training
• Compass AI™ / Compass Enterprise Workflow: A cloud-based software solution enabling image storage, analysis, remote collaboration and EMR integration for healthcare systems
• TeleGuidance: A remote guidance feature allowing real-time ultrasound coaching and collaboration across clinical settings
• AI-Powered Imaging Tools: Auto Bladder Volume, Auto B-Lines, iQ Slice, iQ Fan, Biplane, Needle Viz and Fetal Heart Sounds for automated measurements and image optimization
• Gestational Age AI Tool: A blind-sweep AI tool for rapid fetal age estimation, FDA-cleared in 2026
Strategic Business Lines
• Butterfly Embedded™: A technology licensing and co-development platform expanding ultrasound-on-chip into new modalities beyond medical ultrasound, with nine partner companies as of 2026
• Home ＆ Community Care: An initiative extending handheld ultrasound capability into patient home environments, with first commercial agreement expected in the first half of 2026
Market Position ＆ Certifications
Butterfly Network holds a pioneering position in the global handheld and point-of-care ultrasound market, competing with GE Healthcare, Philips Healthcare and Siemens Healthineers. Key strengths include:
• 15+ years of US innovation heritage in semiconductor-based medical imaging
• Ultrasound-on-Chip Technology: Proprietary silicon-chip platform miniaturizing the entire ultrasound system onto a single semiconductor, leveraging Moore's Law for continuous performance gains
• Regulatory compliance: FDA-cleared; CE marked for European and select global markets since 2019
• Industry recognition: 2024 Prix Galien USA Best Medical Technology for iQ3; TIME's Best Inventions; Fast Company's World Changing Ideas; CNBC Disruptor 50
• Global accessibility: Devices commercially available across Africa, Asia, Australia, Europe, the Middle East, North America and South America
Corporate Timeline
2011 — Founded by Dr. Jonathan Rothberg with a mission to democratize medical imaging
2018 — Launches Butterfly iQ, the world's first handheld single-probe whole-body ultrasound system
2019 — Receives CE Mark clearance for European and international markets
2020 — Introduces Butterfly iQ+ with enhanced image quality and processing power
2021 — Completes SPAC merger with Longview Acquisition Corp and begins trading on NYSE (BFLY); launches iQ+ Vet for veterinary medicine
2022 — Opens new headquarters at 1600 District Avenue in Burlington, Massachusetts
2023 — Appoints Joseph DeVivo as President, Chief Executive Officer and Chairman
2024 — Launches Butterfly iQ3 on the P4.3 semiconductor platform; introduces iQ+ Bladder specialty product; wins Prix Galien USA Best Medical Technology award
2025 — Advances Butterfly Embedded partnerships and Home ＆ Community Care initiatives
2026 — FDA clearance for Gestational Age AI Tool; Butterfly Garden reaches 30 partners; Butterfly Embedded signs ninth partner; first Compass AI enterprise deal closed
Target Markets ＆ Applications
• Point-of-Care Ultrasound (POCUS): iQ series for bedside diagnostics across emergency medicine, critical care and primary care settings
• Hospital ＆ Health System Workflows: Compass AI enterprise software and iQ3 hardware for large-scale imaging integration and remote specialist support
• Veterinary Medicine: iQ+ Vet for animal health diagnostics in clinical and field settings
• Medical Education: Butterfly Academy and ScanLab for training the next generation of ultrasound practitioners
• Home ＆ Community Care: Extending ultrasound capability into patient home environments for virtual and in-home healthcare services
• Embedded Technology Partnerships: Licensing ultrasound-on-chip semiconductor technology to partners developing new modalities and wearable form factors
Contact Information
Global Headquarters
Address: 1600 District Avenue, Burlington, Massachusetts 01803, United States
Investor Relations
Stock: NYSE: BFLY
Website: butterflynetwork.com
Investor Relations: ir.butterflynetwork.com
